socalTECH

FEBRUARY 23, 2009

San Diego-based Newsforce (www.newsforce.com) is a startup which is looking to take advantage of the hunger of the newspaper and media business for revenue, and has created a product which takes press releases and commercial content, and inserts them onto news sites in "sponsored content" blocks. Tell us a little bit about Newsforce?

News 124

News Advertising Press Sites 124

Both Sides of the Table

AUGUST 21, 2011

We now know that the medium has changed the news industry leading to blogs, real-time reporting, integration of text and video, two-way discussions, stories surfaced based on what your friends are reading, etc. So here’s my news for you: People still want telephone calls! They’re not.

Mobile 329

Mobile Advertising Media Marketing 329

Xconomy

SEPTEMBER 9, 2016

For more on that and the rest of the week’s news, fire up the roundup rockets. The agency advised women and their doctors not to use screening tests that claim to detect ovarian cancer. —One cancer screening test got positive news from a federal agency.

Pricing 40

Pricing Startup News Screening 40

Xconomy

JUNE 10, 2016

Plans for new incubators were announced in two different cities. We’ve got those stories, plus a spate of financings and deals, a legal feud, and other news below. The results give the company confidence it can expand its tests to screen for early cancer in high-risk people who are otherwise healthy.

Incubator 67

Incubator Thousand Oaks Screening Pricing 67

Xconomy

APRIL 20, 2018

The biggest news this week was in oncology, hands down. Merck showed that its immunotherapy pembrolizumab (Keytruda) might become a common option for many patients newly diagnosed with advanced lung cancer, but the bigger picture is that the field is moving fast.

Pricing 52

Pricing News Report Develop 52

Both Sides of the Table

MAY 13, 2018

In any event this is a “screening meeting” or as I’ve called on my graphics an “introduction” to the firm. This goes into the heart of my controversial blog post (coming soon! Come back to this blog over the next 2 weeks and I’ll explain. The first meeting is usually with 1–2 people within the VC firm.

Venture Capital 332

Venture Capital Funding Startup Sales 332

Xconomy

JUNE 17, 2016

Familiar biotech names—not necessarily familiar for the right reasons—made news this week in biotech. —News for a group of slumping East Coast biotechs: Christoph Westphal and former Genzyme CEO Henri Termeer both stepped down from the board of Cambridge-based Verastem (NASDAQ: VSTM ), whose shares are worth just over $1.30

News 55

News Technical Review Conference Report 55